# FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

> **Open Intelligence Dossier** · First detected: 2026-09-18 19:00 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Endpoints News, Reuters, Yahoo Finance and Fierce Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxNUUdkel82TlBSZ1JuMjg3eDY1Z0w4anVOcW1xaHBlMWVmSnFMVGhrekUyWmZaMVNOYWc4ckdXT0VVV1FuRzhoeTZvVm5KOW5wMjU2YkZOb1BwWjY4R21mRWw0MHpDVmV1WnBjT0RFeFJlSEdYVGZ1c2xyNGVGa0tFb2diS3puVm1yMHdYVnZTWFA?oc=5) |
| Endpoints News | Updated: Ultragenyx’s new gene therapy will cost $3.95 million | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQR1NVX2lUb0xCYWlFckhWUFdVUnhrVXFDVkVWaHRsZXM5LW9kTG9fTGJVQk03R0p6TmJvR3J2QzBPREFSNHdhdHgwX0FzT1JzLWZHZEctOEtZb2hqY3NQXzRSd1RXVXFVTG9JbWl1SUJOZ2xTeFZ0WWx2X0czQjN0ZE41U0tzcnBmODZMRGszTWR1U3lXQ3VF?oc=5) |
| Reuters | Ultragenyx sets $3.95 million price for rare disease gene therapy | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxOeE90bDVTdWlBazlIN1NQLXJHbklsNk1MQ09JTy1tTHdDd0Jja0tOY09ZeEJJQjJnVW52TzVFa2NSSmdsMHhOQXJiV2VPR0RPYktma2k2OHUtTHItY2F2OEs0M0ZIeTJsQmltNWFpUU8tZDlvMUFtY1F4U0ZfaXFIb3kwaEh3ei1qdmtoLXVMMDZJX2lLemIzblhHWWJ0Nkd2RFYwbm5qempENjFPYk5GYkZhUlNnMFNLZGJYTXFfcTR4UmpC?oc=5) |
| Yahoo Finance | Ultragenyx Gets A ‘Much-Needed Win,’ Says Cantor – Sees $400M Opportunity After FDA Approves Neurodegenerative Disease Therapy | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxOWjJxaWN3Z2xERmlwcURhQW82RmFFQUFEWXpNSFlNVk5wSWg5X1ozeUV3aFNISHkxLXkza1VHS3pobVpkYlJMalJVMXg5WV9XaHMzeUxidzE1cS1HRmNzVXpaU21yQ2dLVTJEbnhjQmllUUVzQXBkYVlyM2p3cS1TVC1PdmppLUxuUUtrVTNKM2JObUhPaEZr?oc=5) |
| Fierce Pharma | FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOaF9GYmFoVU84czdXV2FhSjdNS0VhNHRCTklYeEFqNjlpWU0zYXFjMXpxNEFkeXVLREhiVmFvenJyY0ZLZTNRRnZQc2Y3Tjl2ODZlalpxUjFhZkl5aGZIX2F5QVJYaFZyT3VfaW9FSEZBTi1aNjZUWE1yeDBCazBERVRSajVOeFdUQXVVMDhuajlYZWUwRkVPak5iUGRGcGlTLVhTNzVSVmdRaUJZeERlNg?oc=5) |
| STAT | FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQdVl6aVRmQVhsZWRGNDNKUmVuOXo0Q1dkN3dDYkF5bWZNd29RblRBUnl3OXEtSlowdGx0d2dRZERsYm9LZUVZRFA5eC1pUnRUaWZoVHpQMndDdmt1eC1RQlU5WTFtRlp3SnJPTlZUM3VXcFZ4enZEbzJ5dEhJd0drdVROUUpodHZoUDY5akZ6SQ?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-18/fda-approves-a-new-gene-therapy-for-sanfilippo-syndrome-an-ultra-rare-disease*